Cwm LLC Has $682,000 Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Cwm LLC boosted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 8.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,723 shares of the medical instruments supplier’s stock after buying an additional 133 shares during the period. Cwm LLC’s holdings in West Pharmaceutical Services were worth $682,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently bought and sold shares of WST. Vanguard Group Inc. increased its holdings in shares of West Pharmaceutical Services by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 9,002,632 shares of the medical instruments supplier’s stock valued at $3,170,007,000 after acquiring an additional 104,740 shares during the last quarter. Franklin Resources Inc. increased its holdings in shares of West Pharmaceutical Services by 1.3% during the 4th quarter. Franklin Resources Inc. now owns 2,105,589 shares of the medical instruments supplier’s stock valued at $741,420,000 after acquiring an additional 28,010 shares during the last quarter. Artisan Partners Limited Partnership increased its holdings in shares of West Pharmaceutical Services by 23.2% during the 4th quarter. Artisan Partners Limited Partnership now owns 1,961,063 shares of the medical instruments supplier’s stock valued at $690,530,000 after acquiring an additional 369,792 shares during the last quarter. Brown Advisory Inc. boosted its stake in West Pharmaceutical Services by 8.4% during the 4th quarter. Brown Advisory Inc. now owns 1,414,431 shares of the medical instruments supplier’s stock valued at $498,049,000 after purchasing an additional 109,369 shares during the period. Finally, Norges Bank bought a new stake in West Pharmaceutical Services during the 4th quarter valued at approximately $300,250,000. 93.90% of the stock is owned by institutional investors and hedge funds.

West Pharmaceutical Services Price Performance

Shares of NYSE:WST opened at $328.47 on Friday. The business has a 50 day moving average price of $348.71 and a 200 day moving average price of $361.15. West Pharmaceutical Services, Inc. has a twelve month low of $310.00 and a twelve month high of $415.73. The company has a market cap of $23.93 billion, a price-to-earnings ratio of 43.33, a PEG ratio of 5.69 and a beta of 1.01. The company has a quick ratio of 1.95, a current ratio of 2.61 and a debt-to-equity ratio of 0.03.

West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, April 25th. The medical instruments supplier reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.29 by $0.27. West Pharmaceutical Services had a return on equity of 20.57% and a net margin of 19.42%. The firm had revenue of $695.40 million during the quarter, compared to the consensus estimate of $670.62 million. During the same quarter in the prior year, the company earned $1.98 EPS. The firm’s revenue for the quarter was down 3.0% compared to the same quarter last year. Research analysts predict that West Pharmaceutical Services, Inc. will post 7.76 earnings per share for the current year.

West Pharmaceutical Services Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 7th. Investors of record on Wednesday, July 31st will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Wednesday, July 31st. This represents a $0.80 annualized dividend and a yield of 0.24%. West Pharmaceutical Services’s payout ratio is 10.55%.

Insider Activity at West Pharmaceutical Services

In related news, CEO Eric Mark Green sold 66,000 shares of the stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $366.65, for a total transaction of $24,198,900.00. Following the completion of the sale, the chief executive officer now owns 152,908 shares in the company, valued at approximately $56,063,718.20. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, SVP Silji Abraham sold 1,800 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $330.78, for a total transaction of $595,404.00. Following the sale, the senior vice president now directly owns 2,860 shares in the company, valued at $946,030.80. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Eric Mark Green sold 66,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $366.65, for a total value of $24,198,900.00. Following the sale, the chief executive officer now owns 152,908 shares in the company, valued at $56,063,718.20. The disclosure for this sale can be found here. 0.53% of the stock is owned by corporate insiders.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.